Laura Elledge, NP
Nurse Practitioner · Atlanta, GANPI 1053771915
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $119,729 of the $177,219 with a category attached, or 67.6%. Amgen accounts for 99.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $93,267 and has fallen 99.8% since, to $153 in 2025. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 377 payments — averaging $470.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$176K
- Lundbeck LLC$183
- Daiichi Sankyo Inc.$182
- AstraZeneca$157
- TG Therapeutics, Inc.$149
- Genentech, Inc.$146
- plus $302 from 7 others
What the payments were for
- Consulting fees$8,1005%
- Speaking & faculty fees$119,72968%
- Travel & lodging$43,95025%
- Food & beverage$5,4253%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 353 | $176,098 |
| Lundbeck LLC | 5 | $183 |
| Daiichi Sankyo Inc. | 1 | $182 |
| AstraZeneca | 3 | $157 |
| TG Therapeutics, Inc. | 2 | $149 |
| Genentech, Inc. | 5 | $146 |
| Sanofi | 1 | $117 |
| Biogen | 1 | $72 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Genentech USA, Inc. | 2 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Kedrion Biopharma Inc. | 1 | $24 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$167,162
- INJECTAFER$182
- BRIUMVI$125
- ULTOMIRIS$107
How this compares
$177,219 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Atlanta
- Janice McAlisterAtlanta$221K
- Casey MillerAtlanta$41K
- Kathryn InanAtlanta$17K
- Colby DoepelAtlanta$16K
- Mark HebertAtlanta$15K
- Ashley BlackmonAtlanta$13K
- Alexia CovingtonAtlanta$13K
- Marissa TorresAtlanta$12K
- Hayley TurnerAtlanta$11K
- Regena SpratlingAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.